Acrivon Therapeutics, Inc. (ACRV): 8-K filed Aug 12, 2026

Form type

8-K

Filing date

Aug 12, 2026

Accession number

0001193125-26-346859

Filer

Acrivon Therapeutics, Inc. (CIK 1781174)